Not available
Quote | Dynavax Technologies Corporation (NASDAQ:DVAX)
Last: | $11.585 |
---|---|
Change Percent: | 2.16% |
Open: | $11.3 |
Close: | $11.34 |
High: | $11.72 |
Low: | $11.25 |
Volume: | 647,802 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Dynavax Technologies Corporation (NASDAQ:DVAX)
2024-03-24 07:39:48 ET Summary Dynavax's core asset, HEPISLAV-B, saw a 69% increase in sales in FY23, making the company cash flow positive. The company's CpG 1018 vaccine candidates are advancing in mid-stage trials, with Heplisav potential sales reaching $400 million by FY27. ...
2024-03-23 08:20:06 ET Summary Pandemic era CpG 1018 revenues are gone and unlikely to rekindle. HEPLISAV-B revenues create a reliable growing stream of income. Dynavax is fairly valued. I have followed the changing fortunes of Dynavax ( DVAX) since 01/2017...
Message Board Posts | Dynavax Technologies Corporation (NASDAQ:DVAX)
Subject | By | Source | When |
---|---|---|---|
$DVAX Dynavax Technologies Corp | mick | investorshub | 05/01/2023 2:19:57 PM |
$DVAX Dynavax Technologies Corp | mick | investorshub | 04/30/2023 9:27:42 PM |
$DVAX Dynavax Technologies Corp | mick | investorshub | 04/15/2023 3:45:35 PM |
$DVAX Dynavax Technologies Corp | mick | investorshub | 02/27/2023 1:07:02 AM |
$DVAX Dynavax Technologies Corp | mick | investorshub | 02/21/2023 11:37:23 PM |
News, Short Squeeze, Breakout and More Instantly...
Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
2024-03-22 01:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-11 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference PR Newswire EMERYVILLE, Calif. , Feb. 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializin...